Chis, A.A.; Arseniu, A.M.; Morgovan, C.; Dobrea, C.M.; Frum, A.; Juncan, A.M.; Butuca, A.; Ghibu, S.; Gligor, F.G.; Rus, L.L.
Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics 2022, 14, 1773.
https://doi.org/10.3390/pharmaceutics14091773
AMA Style
Chis AA, Arseniu AM, Morgovan C, Dobrea CM, Frum A, Juncan AM, Butuca A, Ghibu S, Gligor FG, Rus LL.
Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics. 2022; 14(9):1773.
https://doi.org/10.3390/pharmaceutics14091773
Chicago/Turabian Style
Chis, Adriana Aurelia, Anca Maria Arseniu, Claudiu Morgovan, Carmen Maximiliana Dobrea, Adina Frum, Anca Maria Juncan, Anca Butuca, Steliana Ghibu, Felicia Gabriela Gligor, and Luca Liviu Rus.
2022. "Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy" Pharmaceutics 14, no. 9: 1773.
https://doi.org/10.3390/pharmaceutics14091773
APA Style
Chis, A. A., Arseniu, A. M., Morgovan, C., Dobrea, C. M., Frum, A., Juncan, A. M., Butuca, A., Ghibu, S., Gligor, F. G., & Rus, L. L.
(2022). Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy. Pharmaceutics, 14(9), 1773.
https://doi.org/10.3390/pharmaceutics14091773